Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression-Reference-Cited by-同舟云学术

Chemokine receptor antagonists enhance morphine's antinociceptive effect but not respiratory depression

Published:2021-11 Issue: Volume:285 Page:120014
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Inan Saadet,Chen Xiaohong,Eisenstein Eric M.,Meissler Joseph J.,Geller Ellen B.,Tallarida Christopher,Watson Mia,Doura Menahem,Barrett James E.,Cowan Alan,Rawls Scott M.,Adler Martin W.,Eisenstein Toby K.

Funder

U.S. Department of Defense

National Institute on Drug Abuse

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference58 articles.

1. Key Substance Use and Mental Health Indicators in the United States: Results From the 2016 National Survey on Drug Use and Health (NSDUH);Ahrnsbrak,2017

2. Why μ-opioid agonists have less analgesic efficacy in neuropathic pain?;Martinez-Navarro;Eur. J. Pain,2019

3. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain;Arner;Pain,1988

4. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain;Szabo;Proc. Natl. Acad. Sci. U. S. A.,2002

5. The chemokine CX3CL1/fractalkine interferes with the antinociceptive effect induced by opioid agonists in the periacqueductal grey area of rats;Chen;Brain Res.,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in rats;Brain, Behavior, and Immunity;2024-03

2. NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties;Journal of Pharmacology and Experimental Therapeutics;2024-02-26

3. Pharmacological Modulation of the MIP-1 Family and Their Receptors Reduces Neuropathic Pain Symptoms and Influences Morphine Analgesia: Evidence from a Mouse Model;Brain Sciences;2023-03-29

4. APP^swe/PS1^ΔE9 mice exhibit low oxygen saturation and alterations of erythrocytes preceding the neuropathology and cognitive deficiency during Alzheimer's disease;CNS Neuroscience & Therapeutics;2023-03-07

5. Multi-chemokine receptor antagonist RAP-103 inhibits opioid-derived respiratory depression, reduces opioid reinforcement and physical dependence, and normalizes opioid-induced dysregulation of mesolimbic chemokine receptors in rats;Drug and Alcohol Dependence;2022-09